logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On March 30, the company spent HKD 582,000 to repurchase 200,000 shares.

date
21:32 30/03/2026
avatar
GMT Eight
KEEP(03650) has announced that it will spend 582,000 Hong Kong dollars to repurchase 200,000 shares on March 30, 2026.
KEEP (03650) issued a notice to repurchase 200,000 shares at a cost of HK$582,000 on March 30, 2026.
Related Articles
HK Stock
XD Inc (02400) spent HK$7.8768 million on March 30 to repurchase 125,000 shares.
HK Stock
EPI (HOLDINGS)(00689) releases annual performance results, with a net profit attributable to shareholders of HKD 5.719 million, turning from a loss to a profit year-on-year.
HK Stock
HEALTHYWAY INC (02587) released its 2025 annual performance report, with a net profit of 54.338 million yuan, achieving a turnaround from loss to profit compared to the previous year.
XD Inc (02400) spent HK$7.8768 million on March 30 to repurchase 125,000 shares.
HK Stock
EPI (HOLDINGS)(00689) releases annual performance results, with a net profit attributable to shareholders of HKD 5.719 million, turning from a loss to a profit year-on-year.
HK Stock
HEALTHYWAY INC (02587) released its 2025 annual performance report, with a net profit of 54.338 million yuan, achieving a turnaround from loss to profit compared to the previous year.
HK Stock
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
icon
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
icon
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
icon
26/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.